A profit maximization model for sustainable inventory under preservation technology and linear time-dependent holding cost
Croatian operational research review · 2025 · 16 (1) · 85-98
DOI: 10.17535/crorr.2025.0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Croatian operational research review, online erschienen am 04.02.2025. Verfasst von Aashish Aashish und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
This paper presents sustainable inventory model with constant deterioration rate when holding cost is time dependent. Demand rate is price and stock dependent. Preservation technology and carbon emission are considered for more sustainable approach. Shortages are allowed and are fully backlogged. In addition, a mathematical model is constructed to maximize the total profit function and the concavity is shown using three-dimensional graph. A numerical experimentation is carried to compute the total profit and the order quantity. To validate the proposed model, the sensitivity analysis is conducted for the total profit function as well as the order quantity. Results and observations are also discussed along with managerial insights.
Zitieren
APA
Aashish, A., & Kumar, P. (2025). A profit maximization model for sustainable inventory under preservation technology and linear time-dependent holding cost. Croatian operational research review, 16(1), 85-98. https://doi.org/10.17535/crorr.2025.0008
Vancouver
Aashish A, Kumar P. A profit maximization model for sustainable inventory under preservation technology and linear time-dependent holding cost. Croatian operational research review. 2025;16(1):85-98. doi:10.17535/crorr.2025.0008
BibTeX
@article{Aashish2025,
author = {Aashish, Aashish and Kumar, Pavan},
title = {A profit maximization model for sustainable inventory under preservation technology and linear time-dependent holding cost},
journal = {Croatian operational research review},
year = {2025},
volume = {16},
number = {1},
pages = {85--98},
doi = {10.17535/crorr.2025.0008}
}
EUVIMED